Manidipine: Difference between revisions

	WikiDoc Resources for Manidipine
Articles
Most recent articles on Manidipine Most cited articles on Manidipine Review articles on Manidipine Articles on Manidipine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Manidipine Images of Manidipine Photos of Manidipine Podcasts & MP3s on Manidipine Videos on Manidipine
Evidence Based Medicine
Cochrane Collaboration on Manidipine Bandolier on Manidipine TRIP on Manidipine
Clinical Trials
Ongoing Trials on Manidipine at Clinical Trials.gov Trial results on Manidipine Clinical Trials on Manidipine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Manidipine NICE Guidance on Manidipine NHS PRODIGY Guidance FDA on Manidipine CDC on Manidipine
Books
Books on Manidipine
News
Manidipine in the news Be alerted to news on Manidipine News trends on Manidipine
Commentary
Blogs on Manidipine
Definitions
Definitions of Manidipine
Patient Resources / Community
Patient resources on Manidipine Discussion groups on Manidipine Patient Handouts on Manidipine Directions to Hospitals Treating Manidipine Risk calculators and risk factors for Manidipine
Healthcare Provider Resources
Symptoms of Manidipine Causes & Risk Factors for Manidipine Diagnostic studies for Manidipine Treatment of Manidipine
Continuing Medical Education (CME)
CME Programs on Manidipine
International
Manidipine en Espanol Manidipine en Francais
Business
Manidipine in the Marketplace Patents on Manidipine
Experimental / Informatics
List of terms related to Manidipine

Manidipine
Clinical data
ATC code	C08CA11 (WHO) ;
Identifiers
	IUPAC name O3-[2-[4-[Di(phenyl)methyl]piperazin-1-yl]ethyl] O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;
CAS Number	120092-68-4;
PubChem CID	4008;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C35H38N4O6
Molar mass	610.69 g/mol

VisualWikitext

Latest revision as of 20:22, 23 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Sheng Shi, M.D. [2]

Overview

Manidipine (INN) is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.^[1]^[2]^[3]^[4]^[5]

References

↑ Cheer, S.M.; McClellan, K. (2001), "Manidipine: A Review of its Use in Hypertension", Drugs, 61 (12): 1777–99, doi:10.2165/00003495-200161120-00010, PMID 11693466, retrieved 2009-06-20
↑ McKeage, K.; Scott, L.J. (2004), "Manidipine: A Review of its Use in the Management of Hypertension", Drugs, 64 (17): 1923–40, doi:10.2165/00003495-200464170-00011, PMID 15329044, retrieved 2009-06-20
↑ Roca-cusachs, A.; Triposkiadis, F. (2005), "Antihypertensive Effect of Manidipine", Drugs, 65: 11–9, doi:10.2165/00003495-200565002-00003, PMID 16398058, retrieved 2009-06-20
↑ Otero, M.L. (2007), "Manidipine–delapril combination in the management of hypertension", Vascular Health and Risk Management, 3 (3): 255–63, PMC 2293964, PMID 17703633
↑ Mizuno, Kenji (August 1992), "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders", Current Therapeutic Research, 52 (2): 248–253, doi:10.1016/S0011-393X(05)80475-8, retrieved 2009-06-20 Unknown parameter |coauthors= ignored (help)

Template:Calcium channel blockers

[1] Cheer, S.M.; McClellan, K. (2001), "Manidipine: A Review of its Use in Hypertension", Drugs, 61 (12): 1777–99, doi:10.2165/00003495-200161120-00010, PMID 11693466, retrieved 2009-06-20

[2] McKeage, K.; Scott, L.J. (2004), "Manidipine: A Review of its Use in the Management of Hypertension", Drugs, 64 (17): 1923–40, doi:10.2165/00003495-200464170-00011, PMID 15329044, retrieved 2009-06-20

[3] Roca-cusachs, A.; Triposkiadis, F. (2005), "Antihypertensive Effect of Manidipine", Drugs, 65: 11–9, doi:10.2165/00003495-200565002-00003, PMID 16398058, retrieved 2009-06-20

[Otero2007-4] Otero, M.L. (2007), "Manidipine–delapril combination in the management of hypertension", Vascular Health and Risk Management, 3 (3): 255–63, PMC 2293964, PMID 17703633

[5] Mizuno, Kenji (August 1992), "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders", Current Therapeutic Research, 52 (2): 248–253, doi:10.1016/S0011-393X(05)80475-8, retrieved 2009-06-20 Unknown parameter |coauthors= ignored (help)

[1]

[2]

[3]

[4]

[5]

@@ Line 28: / Line 28: @@
 | routes_of_administration =
 }}
-{{CMG}}
+__NOTOC__
+{{SI}}
+{{CMG}}; {{SS}}
-{{EH}}
+==Overview==
-'''Manidipine''' ([[International Nonproprietary Name|INN]]) is [[calcium channel blocker]].
+'''Manidipine''' ([[International Nonproprietary Name|INN]]) is a [[calcium channel blocker]] (dihydropyridine type) that is used clinically as an [[antihypertensive]].<ref>{{Citation
+ | title = Manidipine: A Review of its Use in Hypertension
+ | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200161120-00010.htm
+ | year = 2001
+ | journal = Drugs
+ | pages = 1777–99
+ | volume = 61
+ | issue = 12
+ | last1 = Cheer	 | first1 =  S.M.
+ | last2 =  McClellan	 | first2 =  K.
+ | accessdate = 2009-06-20
+ | pmid = 11693466
+ | doi=10.2165/00003495-200161120-00010}}</ref><ref>{{Citation
+ | title = Manidipine: A Review of its Use in the Management of Hypertension
+ | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200464170-00011.htm
+ | year = 2004
+ | journal = Drugs
+ | pages = 1923–40
+ | volume = 64
+ | issue = 17
+ | last1 = McKeage	 | first1 =  K.
+ | last2 =  Scott	 | first2 =  L.J.
+ | accessdate = 2009-06-20
+ | pmid = 15329044
+ | doi=10.2165/00003495-200464170-00011}}</ref><ref>{{Citation
+ | title = Antihypertensive Effect of Manidipine
+ | url = http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200565002-00003.htm
+ | year = 2005
+ | journal = Drugs
+ | pages = 11–9
+ | volume = 65
+ | last1 = Roca-cusachs	 | first1 =  A.
+ | last2 =  Triposkiadis	 | first2 =  F.
+ | accessdate = 2009-06-20
+ | pmid = 16398058
+ | doi=10.2165/00003495-200565002-00003}}</ref><ref name=Otero2007>{{Citation
+ | title = Manidipine–delapril combination in the management of hypertension
+ | year = 2007
+ | author = Otero, M.L.
+ | journal = Vascular Health and Risk Management
+ | pages = 255–63
+ | volume = 3
+ | issue = 3
+ | pmid = 17703633
+ | pmc = 2293964
+}}</ref><ref>{{Citation
+| doi = 10.1016/S0011-393X(05)80475-8
+| volume = 52
+| issue = 2
+| pages = 248–253
+| last = Mizuno
+| first = Kenji
+| coauthors = Hiroshi Haga, Michihiko Takahashi, Soitsu Fukuchi
+| title = Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders
+| journal = Current Therapeutic Research
+| accessdate = 2009-06-20
+| date = August 1992
+| url = http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VS8-4GHBHXV-5&_user=10&_coverDate=08%2F31%2F1992&_rdoc=5&_fmt=high&_orig=browse&_srch=doc-info(%23toc%236256%231992%23999479997%23600363%23FLP%23display%23Volume)&_cdi=6256&_sort=d&_docanchor=&_ct=16&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=4a139e549c7d88da59d7ebdfe6f44be7
+}}</ref>
+==References==
+{{reflist|2}}
 {{Calcium channel blockers}}
 [[Category:Calcium channel blockers]]
-[[Category:Piperazines]]
+[[Category:Cardiovascular Drugs]]
+[[Category:Drug]]
-{{WH}}
-{{WS}}

Clinical data

ATC code	C08CA11 (WHO)
Identifiers
IUPAC name O3-[2-[4-[Di(phenyl)methyl]piperazin-1-yl]ethyl] O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
CAS Number	120092-68-4
PubChem CID	4008
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₅H₃₈N₄O₆
Molar mass	610.69 g/mol

Manidipine: Difference between revisions

Latest revision as of 20:22, 23 July 2014

Overview

References

Navigation menu

Search